Apr 29, 2020
First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma
Nov 05, 2019
AAGL Announces "Game of Zones:" Surgeons Learn Subspecialty Techniques as Experts Compete for the Stainless-Steel Throne in Vancouver at the 48th Annual Global Congress
Oct 10, 2019
Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent
Sep 05, 2019
iSTAR Medical Announces EUR 40m Series C Financing
Aug 29, 2019
MIGS Devices Continue to Expand Use of Glaucoma Surgery
Apr 23, 2019
Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal
Mar 27, 2019
First Subjects Enrolled in Clinical Study to Evaluate Safety and Efficacy of OMNI(TM) Surgical System for Multiple Micro-Invasive Glaucoma Surgery Procedures
Dec 19, 2018
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market to Reach a Market Size of $1,180.7 Million by 2024 - KBV Research
Aug 13, 2018
Ivantis Announces FDA Approval for Its Innovative Hydrus® Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)
Apr 16, 2018
Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial
Feb 20, 2018
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Expected to Reach $912 Million by 2023 - Allied Market Research
Nov 13, 2017
Ivantis FDA Clinical Trial of the Hydrus® Microstent for Minimally Invasive Glaucoma Surgery (MIGS) Meets Endpoints, Exceeds Outcomes of Past MIGS Trials
Oct 17, 2017
iSTAR Medical Completes Enrolment of First-in-human MIGS Trial
Jun 06, 2017
Research and Markets - Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market, Opportunities and Forecast 2017-2022 Featuring Alcon, Allergan, Glaukos, Ivantis & Santen Pharmaceuticals